Amicus Therapeutics Unveils Significant Conference Plans for September
Amicus Therapeutics Announces Conference Participation
Amicus Therapeutics is excited to share that the management team will be actively participating in several notable investor conferences this upcoming September. The company is dedicated to advancing therapies for people affected by rare diseases, and these conferences represent a significant opportunity to engage with investors and discuss future prospects.
Upcoming Conferences
The first event on the agenda is the Cantor Global Healthcare Conference 2025 set to take place in New York. This event will occur on a Wednesday, where Amicus Therapeutics is scheduled to present at 10:20 a.m. Eastern Time. Following that, the company will be featured at the Morgan Stanley 23rd Annual Global Healthcare Conference 2025, which is also in New York, with a presentation slated for 3:20 p.m. the following Tuesday.
Audio Webcasts for Live Access
For those unable to attend in person, Amicus Therapeutics will provide live audio webcasts of each presentation. These webcasts can be accessed through the corporate website's investors section, allowing stakeholders and interested parties to follow along with the insights shared during the conferences.
Focus on Rare Diseases
Amicus Therapeutics is a global biotechnology firm with a strong focus on developing innovative and effective treatments targeted at rare diseases. The commitment to the patient community drives the company's efforts to create medications that genuinely improve lives. Their pipeline includes several promising therapies that aim to set the standard in the field.
Engagement Through Communication
The company places great importance on transparency and open communication with its investors and stakeholders. This dedication shows that Amicus not only seeks to inform but also to engage with the community about the significant advancements in rare disease treatments.
About Amicus Therapeutics
Amicus Therapeutics (NASDAQ: FOLD) is renowned for its unwavering commitment to patients, continually striving to discover and develop high-quality medicines. The company is on a mission to expand its pioneer pipeline, featuring first-class medical solutions for the rare disease sector.
Follow Amicus for Updates
Investors and interested individuals are encouraged to stay connected through Amicus Therapeutics' official platforms. The company shares updates and news regularly, providing insights into ongoing research achievements and event participation.
Contact Information
Investors:
Contact: Andrew Faughnan
Vice President, Investor Relations
Email: afaughnan@amicusrx.com
Phone: (609) 662-3809
Media:
Contact: Diana Moore
Vice President, Corporate Communications
Email: dmoore@amicusrx.com
Phone: (609) 662-5079
Frequently Asked Questions
What is the purpose of the investor conferences?
The conferences allow Amicus Therapeutics to engage with investors regarding its pipeline and future initiatives.
Are the presentations available for everyone?
Yes, the live audio webcasts can be accessed via the company's corporate website.
What is Amicus Therapeutics focused on?
Amicus is focused on developing innovative treatments for rare diseases, emphasizing patient-centered healthcare.
How does Amicus maintain investor communication?
The company regularly updates its investors and stakeholders through its website and social media platforms.
Who can be contacted for investor inquiries?
Investor inquiries can be directed to Andrew Faughnan, Vice President of Investor Relations, at afaughnan@amicusrx.com.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.